A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
|Articles|June 11, 2014
- June 2014
- Volume 18
- Issue 1
Parent's Addiction Linked to Arthritis
Advertisement
Adults whose parents have a history of substance abuse may be at an increased risk for developing arthritis, according to the results of a study published on March 23, 2014, in the International Journal of Population Research. Respondents of the 2005 Canadian Community Health Survey who reported that at least 1 of their parents had been addicted to drugs or alcohol were ~58% more likely to be diagnosed with arthritis than those who did not report parental addictions.
Articles in this issue
over 12 years ago
Consuming Antioxidants and Fish May Prevent Macular Degenerationover 12 years ago
Test May Aid Diagnosis of Fungal Nail Infectionover 12 years ago
18 Years Strong!over 12 years ago
Pharmacy Times: Leading the Wayover 12 years ago
Odd Allergies: OTC Answers?over 12 years ago
Vitamin D Supplements: Reaping the Benefits from the Right Amountover 12 years ago
Teens Frequently Given Opioids for Headacheover 12 years ago
For Plaque Removal, Straight Toothbrush Beats Angledover 12 years ago
Aspirin May Reduce Ovarian Cancer RiskAdvertisement
Related to this article
A Novo Nordisk-funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, though the findings cannot show causation.
Invasive pneumococcal disease may be the first sign of undiagnosed blood cancers and antibody deficiencies in adults, a new study finds.
A retrospective study from Japan found that oncology pharmacist assessment before medical examination was associated with higher rates of complete adverse event resolution in outpatient chemotherapy.
A new analysis finds a significant weight loss edge for tirzepatide under one estimand but not another; no head-to-head trial exists at these doses.
In SCOUT-HCM, mavacamten reduced the Valsalva LVOT gradient by 48 mm Hg versus placebo in adolescents. REMS, echo monitoring, and CYP interactions still apply in the new population.
September’s pain management coverage examined postoperative nonopioid options, lessons from sickle cell pain research, and pharmacists’ experiences with controlled-substance prescribing.
September’s hematology coverage examined a new definition of myeloma cure, patient preferences for treatment delivery, and emerging strategies for deepening responses.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tirzepatide Linked to More Weight Loss Than Semaglutide 7.2 mg
2
Pharmacist, Advocate, Ally: Delivering Comprehensive Gender-Affirming Care
3
Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
4
September 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
5